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Abstract
Background: The aim of this study was to investigate the association between MCT1 rs1049434 polymorphism and
indirect muscle injuries in elite football players. One hundred and seventy-three male elite Italian football players
(age = 19.2 ± 5.3 years) were recruited from a first-league football club participating at the Official National Italian
Football Championship (Serie A, Primavera, Allievi, Giovanissimi). The cohort was genotyped for the MCT1 rs1049434
polymorphism, and muscle injuries data were collected during the period of 2009–2014 (five football seasons).
Methods: Genomic DNA was extracted using a buccal swab, and genotyping was performed using PCR method.
Structural-mechanical injuries and functional muscle disorder were included in the acute indirect muscle injury
group.
Results: Participants with the MCT1 AA (AA = 1.57 ± 3.07, n = 69) genotype exhibit significantly higher injury
incidents compared to participants with the TT genotype (TT = 0.09 ± 0.25, n = 22, P = 0.04).
Conclusions: The MCT1 rs1049434 polymorphism is associated with the incidence of muscle injuries in elite
football players. We anticipate that the knowledge of athletes’ genetic predisposition to sports-related injuries
might aid in individualizing training programs.
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Key Points
 MCT1 rs1049434 TT genotype could influence the
incidence of muscle injuries in elite football players.
 This study emphasizes a possible future direction in
considering genes that encode for monocarboxylate
transporters within musculoskeletal soft tissues
when examining the individual predisposition of
football players to develop muscle injuries.
 Additional research and replication studies are
needed to support our data and to fully understand
the relationship between predisposition to muscle
injuries in football and the MCT1 rs1049434.
Background
Lactate is the end product of anaerobic glycolysis and is
highly accumulated during high-intensity exercise. Lac-
tate transport across the plasma membrane is mainly
mediated by proton-linked monocarboxylate trans-
porters (MCT1 and MCT4) [1–3] that play a relevant
role in the intracellular pH homeostasis [4]. In fact, the
rapid transport of lactic acid across the plasma mem-
brane is fundamentally important for the metabolism of
almost all cells, including skeletal muscle.
In 1992, Garcia et al. [5] cloned the first monocarbox-
ylate transporter, MCT1, from Chinese hamster ovary
cells and showed that it is expressed, among other tis-
sues, in erythrocytes, skeletal muscle, and heart. Intercel-
lular MCT1 is particularly important in skeletal muscle,
where glycolytic fast twitch muscle fibers produce lac-
tate, which is transported out of the cell through the
monocarboxylate transporter (MCT). Lactate is then
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taken up and oxidized by the oxidative slow twitch muscle
fibers, which express MCT1 [6]. Kinetic analysis of MCT1
has suggested that it translocates a proton (H+) and a
monocarboxylate across the plasma membrane by an or-
dered mechanism in which H+ binding precedes monocar-
boxylate binding and, after translocation across the
plasma membrane, the substrates are sequentially released
in reverse order [4, 7]. However, it is important to note
that the direction of flux is decided by the combined elec-
trochemical gradients of lactate and proton [3].
SLC16A1 is the gene for human MCT1 and it is lo-
cated on chromosome 1, in position 1p13.2-p12. Defects
in SLC16A1 are the cause of symptomatic deficiency in
lactate transport, also known as erythrocyte lactate
transporter defect. Symptoms and signs of muscle injury
on exercise and heat exposure and subnormal erythro-
cyte lactate transport have been related with the pres-
ence of two common single nucleotide polymorphisms
(SNPs) in the SLC16A1 gene [8]. In particular, the A > T
SNP located in protein coding region (coding base
1470), converting #490 Glutamic amino acid to Aspartic
amino acid was associated with a reduction of 35–40 %
in the erythrocytes lactate transport rate in two patients
carrying the T allele [8].
A recent study showed a higher lactate blood accumu-
lation slope in capillary (more arterialized) blood in T
allele carriers than in non-carriers during high intensity
(80 %, 15 repetition maximum (15RM)) circuit weight
training) [9]. The same research group has recently
found a higher venous blood lactate levels in AA geno-
type carriers compared to carriers of the AT and TT ge-
notypes [10].
Lactate transporter defects in skeletal muscle might
provide an explanation for some cases of easy fatigue
and muscle cramping upon exercise due to delayed re-
moval of the protons accumulated during (partially) an-
aerobic work [8]. Muscle fatigue has been shown to
predispose to injury [11].
Muscle injury is one of the major disorders that foot-
ball players are facing. It has been reported that muscle
injuries account for 20 to 37 % of all time loss injuries at
men’s professional level and 18 to 23 % at men’s amateur
level [12, 13]. Muscle injuries are generally classified into
two groups; indirect muscle injuries (can also refer as
“non-contact” and are caused by internal forces) and dir-
ect muscle injuries (caused by external forces). Contu-
sion and laceration are the most common direct muscle
injuries. The severity of the direct injury depends on the
contact force, the contraction state of the affected
muscle at the moment of injury and other factors. How-
ever, the functional muscle disorder and the structural
muscle injuries are the two group inside which can be
classified the indirect muscle injuries (Reviewed by
Mueller-Wohlfahrt et al. [20]). Recent studies have
identified some genetic markers that could influence the
predisposition to injuries in football [14–19]. However, to
date, no study has looked at the MCT1rs1049434 variant.
Given the potential role of MCT1 in muscle soreness
and injuries, the aim of the present study was to analyze
the effect of the MCT1rs1049434 polymorphism on in-
direct muscle injury rates in top-level football players,
during five competitive seasons. We hypothesized that
the presence of the T allele (previously associated with
greater arterial blood lactate levels) could be protective in
developing pathogenesis of indirect muscle injuries due to
the decreased transport mediated by MCT1 proteins from
arterial blood into the muscle fibers for its oxidation.
Methods
Participants
One hundred seventy-three male elite football players
(age 19.4 ± 5.2 years; height 177.1 ± 7.4 cm; weight
69.3 ± 8.8 kg) participated in the study. All participants
have played at the Official National Football Champion-
ship (Serie A, Primavera, Allievi and Giovanissimi) during
five seasons (2009–2014). Participants were all Italian
(Caucasian) for ≥3 generations. The participants trained
for ~8 weeks (25.0 ± 10.3 h per week) in the pre-season
period and ~38 weeks during the competitive season
(10.0 ± 7.4 h per week). Players who join/left the cohort
were included/excluded from the date when they join/left
the team. All participants provided informed written con-
sent, and the study protocol was approved by the Ethics
Committee of the club and it was in accordance with Dec-
laration of Helsinki for Human Research of 1974 (last
modified in 2000).
Study Design
The study design followed the consensus on definitions
and data collection procedures in studies of football in-
juries outlined in the consensus document [21] and by
UEFA [22].
Injuries Data Collection
Data was collected from 25 players (14.4 %) during the
2009–2010 season, 15 players (8.6 %) during the 2009–
2011 season, 14 players (8.0 %) during the 2009–2013
season, 67 players (38.7 %) during the 2012–2013 sea-
son, and 53 players (30.6 %) during 2013–2014 season.
The follow-up time for injuries was between 1 and
5 years. Injury data of players who left the team during
the season, for example, due to a moving to another
team, were included only for the period they were part
of the roster. Players with an existing injury were not ex-
cluded from the study; however, their existing injuries
were recorded and were not included in the study.
An indirect muscle injury was defined as any physical
complaint occurring during practice that prevented a
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player from participating in training or match play for at
least 1 day after the day of the onset [21]. Injuries were
categorized under four degrees of severity based on the
number of days’ absence: minimal (code 1; 1–3 days),
mild (code 2; 4–7 days), moderate (code 3; 8–28 days),
and severe (code 4; >28 days) [21]. The registration of a
muscle injury was based on a clinical examination by the
team medical staff. Time loss due to injury was recorded
on a weekly basis by the team’s medical staff (physicians
and coaches) using a standardized injury report form
during the preseason and during the regular season.
Ultrasound and magnetic resonance imaging scans
were used to morphologically classify the injuries.
Muscle injuries included in the study were classified ac-
cording to a scheme devised by Muller-Wohlfarth [20]
derived from a recent consensus statement on sports in-
juries in relation to indirect mechanisms of injury
(Table 1).
Participants with direct muscle injury (contusion and
laceration) were excluded from the study.
Injury incidence was calculated per 1000 h of training
exposure ((∑ number of muscle injuries/∑ h training ex-
posure)×1000). Training exposure was defined as any
team-based or individual physical activity, conducted
under the control or guidance of the team’s coaching
and fitness staff that was aimed at maintaining or im-
proving players’ football skills or physical condition.
Matches between teams were considered to be training
exposure. Any match activity that was part of a player’s
rehabilitation from injury was not recorded as a match
exposure. The follow-up time was accounted in the in-
jury incident calculation.
DNA Analysis
Genomic DNA was extracted from buccal swab using a
QIAamp DNA Minikit (QIAGEN, Hilden, Germany).
Concentration of extracted DNA was determined by
fluorometric method (through Qubit by Invitrogen). On
average, the DNA concentration registered was 20 μg/ml,
which is sufficient for performing PCR.
Following performing the PCR, an electrophoresis on
agarose gel was carried out as quality control to verify
the purity of the PCR products. Genomic DNA from the
subjects was analyzed by polymerase chain reaction
(PCR) following the protocol previously published [9].
The primers used for amplification were as follows [8]:
sense primer 5′-ACACATACTGGGCATGTGGC-3′
(1455–1474); antisense primer 5′-AAA TCCCATCAA
TGA ACAACTGGTATGATTTCCAC-3′ (1807–1841).
Using the primers and the missense polymorphism
(rs1049434) described by Cupeiro et al. [9], we searched
the sequence on gene bank. Through the Neb Cutter
tool (http://tools.neb.com/NEBcutter2/index.php), we
individuated the restriction enzyme BccI that allows to
discriminate the presence or absence of missense poly-
morphism A1470T. This enzyme recognizes the se-
quence 3′-GGTAG-5′ and produces three fragments in
the mutate sequence (TT: 14,171, and 202 bp), whilst
only two fragments (AA: 14 and 373 bp) are generated
in the wild sequence. Heterozigotes AT were individu-
ated by four fragments: 14, 171, 202, and 373 bp.
Statistical Analysis
Levene’s tests were performed to verify the homogeneity
of variances. ANOVA was used to examine the differ-
ences between genotype (or allele) groups and continu-
ous data. Where appropriate, a Fisher LSD post hoc
analysis was used to determine which of the three geno-
types were significantly different from each other.
Hardy-Weinberg equilibrium was calculated using
Genepop version 4.0.10 (http://genepop.curtin.edu.au).
The P value for significance was set at P < 0.05.
Results
The estimated total incidence was 1.25 ± 3.0 muscles in-
juries per 1000 h of exposure. A total of 107 injuries re-
corded during the five seasons accounted for a loss of
2391 days, that is, absence from training in the pre-
season and regular competitive season. The mean lay-off
time for indirect muscle injuries amounted to 13.6 days.
Injuries were most likely to be in the lower extremities
(thigh 82.2 %; leg 12.1 %). Muscle injuries in the lower
extremities involved the biceps femoris (26.4 %), the rec-
tus femoris (22.9 %), the gastrocnemius (11.4 %), the
Table 1 Classification of indirect muscle disorders and injuries
A) Functional muscle disorder Type 1: Overexertion-related muscle disorder Type 1a: Fatigue-induced muscle disorder
Type 1b: Delayed-onset muscle soreness (DOMS)
Type 2: Neuromuscular muscle disorder Type 2a: Spine-related neuromuscular muscle disorder
Type 2a: Muscle-related neuromuscular muscle disorder
B) Structural muscle injury Type 3: Partial muscle tear Type 3a: Minor partial muscle tear
Type 3b: Moderate partial muscle tear
Type 4: (Sub)total tear Type 4a: Subtotal or complete muscle tear
Type 4b: Tendinous avulsion
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adductor magnus (11.4 %), the adductor longus (8.0 %),
the ileopsoas (5.7 %), the semitendinosus (3.4 %), the
semimembranosus (2.2 %), the adductor brevis (2.2 %),
the popliteus (1.1 %), the sartorius (1.1 %), the soleus
(1.1 %), the vastusmedialis (1.1 %), and the vastusinter-
medius (1.1 %). Table 2 reports the MCT1 genotype
distribution based on the severity of muscle injuries
resulting in absence from training sessions or matches.
Table 3 reports the number and percentage of muscle
injuries classified according to the Munich Consensus
Statement.
The MCT1rs1049434 genotype distribution (39.8 %
AA, n = 69; 47.3 % AT, n = 82; 12.7 % TT, n = 22) was
in Hardy-Weinberg equilibrium (P = 0.486) confirming
no genotyping errors, population subdivision, viability
selection, or systematic mating. Age (P = 0.322), height
(P = 0.366), and weight (P = 0.353) were not signifi-
cantly differentiated between the three genotype
groups as well as the number of seasons played by the
football players (P = 0.060) (Table 4).
Regarding the muscle injury variables, significant
differences were found between MCT1 genotypes and
incidence of muscle injuries (P = .048). In detail, foot-
ball players with the TT genotype had lower incidence
of muscle injuries compared to AA genotype carriers
(AA = 1.57 ± 3.07, n = 69; TT = 0.09 ± 1.25; P = .044).
No significant difference was found between geno-
types and the severity of injuries (P > 0.05). Moreover,
there was no correlation between the number of the
recovery days and the SNP.
Finally, no significant difference between injuries from
muscles that are primarily slow twitch compared to
muscles that are primarily fast twitch was observed. In
fact, the most injured muscles were the biceps femoris
and rectus femoris that are primarily slow twitch and
fast twitch, respectively.
Discussion
The main finding of the present study was that the
MCT1 rs1049434 AA genotype is associated with higher
incidence of injuries in elite football players. The mean
incidence of indirect muscle injuries shown in the
present study is in line with the recent published data
(1.48; range 1.42 to 1.55) [23] on epidemiological and
clinical muscle injuries in male elite football players
(UEFA Elite League study of 2287 thigh injuries (2001–
2013)).
Lactic acid is mainly dissociated into La− anions and
protons (H+) at physiological pH status. During exercise
and muscle contractions, muscle and blood anions (La−)
and protons (H+) are typically raising up, depending on
the exercise intensity [24, 25]. Lactic acid transport
across the plasma membrane is fundamental for the me-
tabolism and pH regulation of all cells, removing lactic
acid produced by glycolysis and allowing uptake by those
cells utilizing it for gluconeogenesis (liver and kidney) or
as a respiratory fuel (heart and red muscle). Previous re-
searches have argued that any detrimental effects of lac-
tic acid on muscle and exercise performance are due to
H+ rather than La− [26], even if other evidences have
given alternative explanations of the biochemistry of
metabolic acidosis [27]. Muscles predominantly com-
posed of oxidative fibers (e.g., soleus) express consider-
able amounts of MCT1 and very little MCT4 [28, 29],
whereas muscles with a large proportion of fast twitch,
glycolytic fibers (e.g., white gastrocnemius) express pri-
marily MCT4 and very little MCT1, which have different
kinetic properties [29]. Both MCT1 and MCT4 partici-
pate in the cell–cell lactate shuttle, whereas MCT1 facil-
itates operation of the intracellular lactate shuttle [30].
Cupeiro et al. [9] have shown an association between
the MCT1 rs1049434 polymorphism and lactate accu-
mulation; higher capillary lactate accumulation was
noted in men carrying the T allele during high-intensity
circuit training. More recently, Cupeiro et al. [10] pub-
lished another study in which they found a higher lactate
accumulation in AA males, which would reflect a higher
release of this molecule from the active fiber to the
blood. Nevertheless, with the data available, the authors
cannot conclude if the differences found between the
two studies are due to the different blood type analyzed
(capillary vs. venous), different training protocols used,
or different muscle fiber proportions within each indi-
vidual [31].
On the bases of the accepted “cell-to-cell lactate shut-
tle” model, the lactate movement across the sarcolemma
during exercise is mediated by monocarboxylate trans-
porters MCT1and MCT4 that are primarily responsible
for lactate uptake from the circulation and lactate extru-
sion out of muscle, respectively [32]. Therefore, if we
Table 2 MCT1 genotype distribution based on the severity of muscle injuries resulting in absence from training sessions or matches
Degree of severity Number of injuries % of total injuries MCT1 genotype distribution
AA (%) AT (%) TT (%)
Minimal (1–3 days) 5 4.7 3 (60.0) 2 (40.0) 0 (0)
Mild (4–7 days) 19 17.8 10 (55.5) 8 (44.4) 0 (0)
Moderate (8–28 days) 56 52.3 15 (41.6) 19 (52.7) 2 (5.5)
Severe (>28 days) 27 25.2 15 (60.0) 8 (32.0) 2 (8.0)
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consider our results within this model, we could
hypothesize that the highest incidence of muscle injuries
displayed by football players with AA genotype could be
due to acidic intracellular environment created by
muscle activity due to the elevated lactate transport from
arterial blood into the muscle fibers for its oxidation, as
noted in the Cupeiro at al. study [10].
The possible link between muscle injuries and lactate
level could be sought in the variations in lactate trans-
porter that results in an acidic intracellular environment
created by muscle activity with consequent degeneration
of muscle and release of myoglobin and creatine kinase
[33–35]. This factor might compromise extreme per-
formance in healthy individuals. Considering that muscle
fatigue has been shown to predispose to injury [11], lac-
tate transporter variations in skeletal muscle might pro-
vide an explanation for some cases of muscle injuries
due to the higher intramuscular lactate concentration,
and genetic variations can explain some of the predis-
position to injuries.
The primary limiting factor in genetic association
studies is the need to recruit large groups of cases (elite
athletes in this case) to overcome the obvious barrier of
large sample size for detecting genetic associations. In
regard to that, we stress that our sample is extremely
homogeneous in terms of the level of the players (all
elite-level football players), geographical origin of the
participants (all Italians and Caucasians), sex (all males),
and team (all from the same team). Hence, their expos-
ure to training loads and injuries and other confounding
variables are well controlled.
A specific limitation in the present study is lack of
data on intramuscular lactate concentration that could,
potentially, assist clarifying the physiological mechanism
behind the genotype:phenotype association. Although
our study may pave the way in looking at this specific
SNP as potential genetic marker, more muscle-related
injury and replication studies in larger cohorts as well as
studies with more injury-related phenotypes are required
to confirm this association.
Conclusions
In conclusion, we found that the MCT1 rs1049434 poly-
morphism is associated with the incidence of muscle in-
juries in elite football players. Additional research is
required to support our data and to fully elucidate the
relationship between predisposition to muscle injuries in
football and the MCT1 rs1049434 polymorphism.
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